Literature DB >> 28445206

Independent effects of blood pressure and parathyroid hormone on aortic pulse wave velocity in untreated Chinese patients.

Yi-Bang Cheng1, Li-Hua Li, Qian-Hui Guo, Fei-Ka Li, Qi-Fang Huang, Chang-Sheng Sheng, Ji-Guang Wang, Jan A Staessen, Yan Li.   

Abstract

OBJECTIVE: Whether or not calcium-regulating hormones stiffen arteries independent of blood pressure (BP) is uncertain. We investigated the independent associations of carotid-femoral pulse wave velocity (PWV) with 25-hydroxy-vitamin D [25(OH)D], parathyroid hormone (PTH) and 24-h ambulatory BP in untreated Chinese patients.
METHODS: Consecutive untreated patients referred for ambulatory BP monitoring were recruited. PWV was measured with a high-fidelity micromanometer and the SphygmoCor software (AtCor Medical, West Ryde, New South Wales, Australia). Serum 25(OH)D and PTH were determined by electrochemiluminescence immunoassay. Analysis of variance, single and multiple regressions were applied for analyses.
RESULTS: In 1052 untreated patients (50.7% women; mean age, 51 years), PWV averaged 7.8 m/s, 24-h SBP/DBP 126.5/81.7 mmHg, serum 25(OH)D and PTH 36.0 nmol/l and 61.6 pg/ml, respectively. In multivariable-adjusted analyses, BP (P < 0.001) and PTH (P = 0.012) increased from less than 25th to at least 75th percentile of the PWV distribution. In continuous analyses, PWV independently increased by 0.40/0.23 m/s per 1-SD increment in SBP/DBP (P < 0.001) and by 0.14 m/s for a doubling of serum PTH (P = 0.029). Associations of PWV with BP were tighter than with PTH (P < 0.001). In pathway analysis, the effect of PTH on PWV did not run via serum or urinary calcium (P = 0.65), but PTH had both a direct (P = 0.026) and a BP-mediated indirect effect (P = 0.043) on PWV. In none of our analyses were PWV associated with serum 25(OH)D.
CONCLUSION: Arterial stiffness, as assessed by PWV, independently increased both with BP and with PTH, but BP remains the main driver of arterial stiffening.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28445206     DOI: 10.1097/HJH.0000000000001395

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  5 in total

Review 1.  Arterial Stiffness in Thyroid and Parathyroid Disease: A Review of Clinical Studies.

Authors:  Andrea Grillo; Vincenzo Barbato; Roberta Maria Antonello; Marco Fabio Cola; Gianfranco Parati; Paolo Salvi; Bruno Fabris; Stella Bernardi
Journal:  J Clin Med       Date:  2022-06-01       Impact factor: 4.964

2.  Parathyroid hormone may play a role in the pathophysiology of primary hypertension.

Authors:  Lasse Oinonen; Antti Tikkakoski; Jenni Koskela; Arttu Eräranta; Mika Kähönen; Onni Niemelä; Jukka Mustonen; Ilkka Pörsti
Journal:  Endocr Connect       Date:  2021-01       Impact factor: 3.335

3.  A Retrospective Cohort Study of the Association between Serum Osteopontin Levels and Aortic Stiffness in Hypertensive Patients.

Authors:  Yuan-Chieh Chang; Jen-Pi Tsai; Ji-Hung Wang; Bang-Gee Hsu
Journal:  Int J Environ Res Public Health       Date:  2022-01-02       Impact factor: 3.390

Review 4.  Aortic Stiffness: Epidemiology, Risk Factors, and Relevant Biomarkers.

Authors:  Rebecca Angoff; Ramya C Mosarla; Connie W Tsao
Journal:  Front Cardiovasc Med       Date:  2021-11-08

5.  Serum levels of sclerostin as a potential biomarker in central arterial stiffness among hypertensive patients.

Authors:  Yu-Chi Chang; Bang-Gee Hsu; Hung-Hsiang Liou; Chung-Jen Lee; Ji-Hung Wang
Journal:  BMC Cardiovasc Disord       Date:  2018-11-27       Impact factor: 2.298

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.